TAT 2019 – International Congress on Targeted Anticancer Therapies
The home of phase 1 oncology
Paris, France - 25 Feb - 27 Feb 2019
The TAT congress is the premier forum for discussion of early phase drug development and translational research.
Leaders from academia and industry, clinicians, researchers and regulators work together to speed up the development of new anti-cancer treatments for better patient outcomes.
The TAT Congress series has been at the forefront of revolutionary transformation in early drug development and has succeeded in broadening the conversation on phase I trials to include a wide circle of stakeholders.
Participating in TAT 2019 will put you at the heart of discussions shaping the most promising paths for developing new therapeutics. Take the opportunity to shape the future of drug development together with the world’s most renowned experts.
We hope to see you at TAT 2019!
-
Programme
Access the online programme for TAT 2019 – Targeted Anticancer Therapies!
-
Registration
Register online for TAT 2019 - Individuals only.
-
Congress Coverage
Access all the congress resources: slides, presentations, news, press releases and much more.
-
Map & Venue
Locate the venue for TAT 2019 on an interactive map
-
-
-
Travel & Accommodation
Information regarding travel to and from the TAT venue in Paris, France
-
Abstracts
The abstract submission for TAT 2019 is now closed
-
Press & Media
Information for media representatives including press accreditation
-
Contacts
Get in touch with the organisers of TAT 2019 – Targeted Anticancer Therapies. Contact details here